Stefano Mangiola

Employment

• Walter and Eliza Hall Institute of Medical Research

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (51)

• Re-evaluating the benefit of training scale in cell foundation models
  2026 DOI: 10.64898/2026.06.04.730272
  +Save
• Multi‑omic and spatial analysis reveals tumour‑derived paracrine signals drive suppressive macrophage polarisation via activation of the cAMP-CREB axis in glioblastoma
  2026 DOI: 10.64898/2026.02.19.706754
  +Save
• Deciphering Gut Microbiome in Colorectal Cancer via Robust Learning Methods
  Genes 2025 DOI: 10.3390/genes16040452
  +Save
• cellsig plug-in enhances CIBERSORTx signature selection for multidataset transcriptomes with sparse multilevel modelling
  Bioinformatics 2023 DOI: 10.1093/bioinformatics/btad685
  +Save
• The circulating immune cell landscape stratifies metastatic burden in breast cancer patients
  2023 DOI: 10.1101/2023.11.01.565223
  +Save
• sccomp: Robust differential composition and variability analysis for single-cell data
  Proceedings of the National Academy of Sciences 2023 DOI: 10.1073/pnas.2203828120
  +Save
• Taurine deficiency as a driver of aging
  Parminder Pal Singh, Kishore Gollapalli, Stefano Mangiola +53 more
  Science 2023 DOI: 10.1126/science.abn9257
  +Save
• A multi-organ map of the human immune system across age, sex and ethnicity
  2023 DOI: 10.1101/2023.06.08.542671
  +Save
• Data from Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma
  2023 DOI: 10.1158/2326-6066.c.6550431.v1
  +Save
• Data from Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma
  2023 DOI: 10.1158/2326-6066.c.6550431
  +Save
• Supplementary Figures from Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma
  2023 DOI: 10.1158/2326-6066.22543851.v1
  +Save
• Supplementary Figures from Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma
  2023 DOI: 10.1158/2326-6066.22543851
  +Save
• Supplementary Table S1 from Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma
  2023 DOI: 10.1158/2326-6066.22543848.v1
  +Save
• Supplementary Table S1 from Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma
  2023 DOI: 10.1158/2326-6066.22543848
  +Save
• Cell signaling activation and extracellular matrix remodeling underpin glioma tumor microenvironment heterogeneity and organization
  Cellular Oncology 2023 DOI: 10.1007/s13402-022-00763-9
  +Save
• IL17RB and IL17REL Expression Are Associated with Improved Prognosis in HPV-Infected Head and Neck Squamous Cell Carcinomas
  Pathogens 2023 DOI: 10.3390/pathogens12040572
  +Save
• Somatic mutation landscape in a cohort of meningiomas that have undergone grade progression
  BMC Cancer 2023 DOI: 10.1186/s12885-023-10624-9
  +Save
• The tidyomics ecosystem: Enhancing omic data analyses
  bioRxiv 2023 DOI: 10.1101/2023.09.10.557072
  +Save
• Robust differential composition and variability analysis for multisample cell omics
  2022 DOI: 10.1101/2022.03.04.482758
  +Save
• MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer
  Prostate Cancer and Prostatic Diseases 2021 DOI: 10.1038/s41391-021-00379-4
  +Save